MX2015011934A - Composiciones nutricionales que contienen un componente peptidico con propiedades antiinflamatorias y usos de las mismas. - Google Patents
Composiciones nutricionales que contienen un componente peptidico con propiedades antiinflamatorias y usos de las mismas.Info
- Publication number
- MX2015011934A MX2015011934A MX2015011934A MX2015011934A MX2015011934A MX 2015011934 A MX2015011934 A MX 2015011934A MX 2015011934 A MX2015011934 A MX 2015011934A MX 2015011934 A MX2015011934 A MX 2015011934A MX 2015011934 A MX2015011934 A MX 2015011934A
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- nutritional compositions
- peptide component
- protein
- compositions containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 102000013691 Interleukin-17 Human genes 0.000 abstract 1
- 108050003558 Interleukin-17 Proteins 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Pediatric Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a composiciones nutritivas que comprenden una fuente del equivalente de proteína, en donde 20% a 80% de la fuente del equivalente de proteína incluyen un componente del péptido que comprende la SEC ID NO 4, SEC ID NO 13, SEC ID NO 17, SEC ID NO 21, SEC ID NO 24, SEC ID NO 30, SEC ID NO 31, SEC ID NO 32, SEC ID NO 51, SEC ID NO 57, SEC ID NO 60, y SEC ID NO 63; y 20% a 80% de la fuente del equivalente de proteína comprende una proteína intacta, una proteína hidrolizada parcialmente, o una combinación de las mismas. La descripción se refiere además a métodos de reducción de la respuesta inflamatoria y/o a la producción de citocinas pro-inflamatorias, es decir la interleucina 17, por la provisión de las composiciones nutritivas a un sujeto objetivo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/833,094 US8889633B2 (en) | 2013-03-15 | 2013-03-15 | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
PCT/US2014/023608 WO2014150558A1 (en) | 2013-03-15 | 2014-03-11 | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015011934A true MX2015011934A (es) | 2015-12-01 |
MX365415B MX365415B (es) | 2019-06-03 |
Family
ID=50483515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015011934A MX365415B (es) | 2013-03-15 | 2014-03-11 | Composiciones nutricionales que contienen un componente peptidico con propiedades antiinflamatorias y usos de las mismas. |
Country Status (18)
Country | Link |
---|---|
US (2) | US8889633B2 (es) |
EP (1) | EP2983531B1 (es) |
CN (1) | CN105072928B (es) |
AR (1) | AR095332A1 (es) |
AU (1) | AU2014237014B2 (es) |
BR (1) | BR112015018335A2 (es) |
CA (1) | CA2905799C (es) |
ES (1) | ES2736313T3 (es) |
HK (1) | HK1216976A1 (es) |
MX (1) | MX365415B (es) |
MY (1) | MY172218A (es) |
NZ (1) | NZ710020A (es) |
PE (1) | PE20151978A1 (es) |
PH (1) | PH12015502071B1 (es) |
RU (1) | RU2015140269A (es) |
SG (1) | SG11201505689PA (es) |
TW (1) | TW201521603A (es) |
WO (1) | WO2014150558A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10251928B2 (en) * | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
US20170020950A1 (en) * | 2015-07-23 | 2017-01-26 | Mead Johnson Nutrition Company | Methods for modulating kinases |
BR112018008833A8 (pt) * | 2015-11-09 | 2019-02-26 | Mjn Us Holdings Llc | composições nutricionais compreendendo lactobacillus rhamnosus gg, assim como butirato de dieta e/ou um composto para estimulação de formação de butirato endógeno |
US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
WO2017117121A1 (en) | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
RU2659240C2 (ru) * | 2016-05-23 | 2018-06-29 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) | Способ получения функционального продукта питания для реабилитации онкологических больных |
CA3060243A1 (en) | 2017-04-17 | 2018-10-25 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
CA3130834A1 (en) | 2019-02-22 | 2020-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
GB2608587A (en) * | 2021-06-25 | 2023-01-11 | Mjn Us Holdings Llc | Use of extensively hydrolysed protein |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2064092C2 (de) | 1970-12-28 | 1983-06-01 | Bayer Ag, 5090 Leverkusen | Inhibitoren für Glykosidhydrolasen aus Actinomyceten |
US3937817A (en) | 1973-02-28 | 1976-02-10 | Bayer Aktiengesellschaft | Pharmaceutical compositions containing a saccharase inhibitor |
US4016260A (en) | 1974-07-22 | 1977-04-05 | Toyama Chemical Co., Ltd. | Novel polypeptide produced by pseudomonas |
FR2474828B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application |
FR2474829B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
US4491589A (en) | 1982-05-17 | 1985-01-01 | The Trustees Of Columbia University In The City Of New York | Amino acid solutions for parenteral nutrition and methods of formulation and use |
DK589785A (da) | 1985-12-18 | 1987-06-19 | Samuelsson Ernst Gunnar | Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet |
IT1190349B (it) | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle |
FR2608050B1 (fr) | 1986-12-15 | 1990-04-13 | Bellon Labor Sa Roger | Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique |
US5230902A (en) | 1988-04-29 | 1993-07-27 | Immunotec Research Corporation | Undenatured whey protein concentrate to improve active systemic humoral immune response |
US5102871A (en) | 1989-04-24 | 1992-04-07 | Kyowa Hakko Kogyo Co., Ltd. | Nutrient composition |
FI904074A0 (fi) | 1989-08-28 | 1990-08-17 | Milupa Ag | Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk. |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
PH30997A (en) | 1990-03-12 | 1997-12-23 | Ciba Geigy | Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes. |
ZA92452B (en) | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
GB9310472D0 (en) | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
GB9312369D0 (en) | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
US5405637A (en) | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
US5723446A (en) | 1993-12-23 | 1998-03-03 | Nestec Ltd. | Enteral formulation designed for optimized nutrient absorption and wound healing |
US5605893A (en) | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
US5643880A (en) | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
AU691362B2 (en) | 1994-11-04 | 1998-05-14 | New Zealand Dairy Board | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
US5821217A (en) | 1995-10-27 | 1998-10-13 | Beth Israel Deaconess Medical Center, Inc. | Enteral formulation: low in fat and containing protein hydrolysates |
IT1277964B1 (it) | 1995-12-27 | 1997-11-12 | Biosistema Di Pier Luigi Spara | Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso |
KR100194074B1 (ko) | 1996-02-21 | 1999-06-15 | 박종헌 | 글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제 |
IL127684A0 (en) | 1996-07-17 | 1999-10-28 | Nicada Inc | Composition for appetite suppression |
KR100221124B1 (ko) | 1996-09-23 | 1999-10-01 | 한상기 | 신규한 카제인 및 그 제조방법 |
NL1005037C2 (nl) | 1997-01-17 | 1998-07-20 | Nl Zuivelonderzoek Inst | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
EP1106181A4 (en) | 1998-08-12 | 2004-12-15 | Morinaga Milk Industry Co Ltd | NUTRITIONAL COMPOSITION TO PREVENT HYPERLIPOPROTEINEMIA |
US6077558A (en) | 1998-12-23 | 2000-06-20 | Bristol-Myers Squibb Company | Elemental nutritional products |
US6905702B1 (en) | 1999-11-08 | 2005-06-14 | Children's Hospital Los Angeles | Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
DE69930464D1 (de) | 1999-12-30 | 2006-05-11 | Kerry Group Services Ltd | Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung |
NL1014380C2 (nl) | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Darmwandversterkend voedingsmiddel. |
US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
US7666996B2 (en) | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
TWI268138B (en) | 2000-05-11 | 2006-12-11 | Kanebo Seiyaku Ltd | Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same |
AU2001234090B2 (en) | 2000-06-28 | 2007-03-15 | Fuji Nihon Seito Corporation | Novel inulin synthase and process for producing inulin by using the same |
GB0016189D0 (en) | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
WO2002032231A1 (en) | 2000-10-19 | 2002-04-25 | Edens, Luppo | Protein hydrolysates |
WO2003005836A2 (en) | 2001-07-10 | 2003-01-23 | Trustees Of Boston University | Modified-fat nutritional products useful for preventing or treating obesity |
EP1406509B1 (en) | 2001-07-18 | 2007-09-12 | DSM IP Assets B.V. | Process for the hydrolysis of milk proteins |
DE10149668A1 (de) | 2001-10-09 | 2003-04-10 | Numico Res B V | Insulinmimetische Aminosäuresequenzen |
JP2003137804A (ja) | 2001-10-31 | 2003-05-14 | Morinaga Milk Ind Co Ltd | インターロイキン−18誘導剤 |
AU2002366037B2 (en) | 2001-11-21 | 2005-11-03 | Morinaga Milk Industry Co., Ltd. | Novel peptide having angiotensin convertase inhibitory effect |
EP1359157A1 (en) | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Metallo-proteinase inhibitory agent |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
US20050256057A1 (en) | 2002-06-04 | 2005-11-17 | Luppo Edens | Protein hydrolysate rich in tripeptides |
FR2841473B1 (fr) | 2002-06-27 | 2004-09-17 | Ingredia | Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires |
EP1534314B1 (en) | 2002-09-04 | 2014-10-22 | DSM IP Assets B.V. | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
TWI317636B (en) | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
AU2003277644A1 (en) | 2002-11-29 | 2004-06-23 | Morinaga Milk Industry Co., Ltd. | Cysteine protease inhibitor |
DE60335216D1 (de) | 2002-12-29 | 2011-01-13 | Nissan Chemical Ind Ltd | Adiponektin-rezeptor und dafür kodierendes gen |
ZA200507880B (en) | 2003-05-05 | 2006-12-27 | Unilever Plc | Hydrolysed casein product comprising tripeptides IPP and/or VPP |
HUE044812T2 (hu) | 2003-09-23 | 2019-11-28 | Dsm Ip Assets Bv | Prolinspecifikus endoproteázok alkalmazása peptidek és fehérjék hidrolízisére |
RU2388478C2 (ru) | 2003-10-24 | 2010-05-10 | Н.В. Нютрисиа | Иммуномодулирующие олигосахариды |
BE1015863A6 (nl) | 2004-01-19 | 2005-10-04 | Huybrechts Lucas | Anticariogene proteinen & peptiden & sacchariden. |
AU2005207891B2 (en) | 2004-01-28 | 2010-04-01 | Andromeda Biotech Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
EP1568707A1 (en) | 2004-02-26 | 2005-08-31 | Puleva Biotech, S.A. | Antihypertensive peptides from casein hydrolysates |
MXPA06010014A (es) | 2004-03-01 | 2007-03-07 | Peptera Pharmaceuticals Ltd | Peptidos derivados de la caseina y usos terapeuticos de los mismos. |
WO2005117933A1 (en) | 2004-05-27 | 2005-12-15 | Campina Nederland Holding B.V. | Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition |
DE102004040452A1 (de) | 2004-08-20 | 2006-02-23 | N.V. Nutricia | Peptidgemisch |
KR100560127B1 (ko) | 2004-09-04 | 2006-03-13 | 한국기초과학지원연구원 | 인산화 단백질 분석용 겔-내 표지화 및 겔-내 단리 방법및 이를 이용한 단백질의 인산화 위치 동정 방법 |
EP1811867A2 (en) | 2004-11-12 | 2007-08-01 | N.V. Nutricia | Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
DK1831361T3 (da) | 2004-12-23 | 2012-05-14 | Campina Nederland Holding Bv | Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse |
ATE491349T1 (de) | 2005-01-18 | 2011-01-15 | Dsm Ip Assets Bv | Neue nutrazeutika-zusammensetzungen |
US8129337B2 (en) | 2005-02-03 | 2012-03-06 | Dsm Ip Assets B.V. | Compositions comprising epigallocatechin gallate and protein hydrolysate |
AU2006212485B2 (en) | 2005-02-09 | 2010-03-11 | Unilever Plc | Food products comprising hydrolysed milk solids with improved taste |
DE602006020028D1 (de) | 2005-04-28 | 2011-03-24 | Unilever Nv | Gesundheitsfördernde peptide und sie enthaltende zusammensetzungen |
US20090131331A1 (en) | 2005-04-28 | 2009-05-21 | Dsm Ip Assets B.V. | Novel Nutraceutical Compositions |
US20090074893A1 (en) | 2005-04-29 | 2009-03-19 | Campina Nederland Holding B.V. | Antiviral peptides |
US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
ES2319475B1 (es) | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
ES2350907T3 (es) | 2005-07-01 | 2011-01-28 | N.V. Nutricia | Nutrición para bebés con proteínas hidrolizadas. |
GB0523806D0 (en) | 2005-11-23 | 2006-01-04 | Micromass Ltd | Mass spectrometer |
US8431531B2 (en) | 2005-11-30 | 2013-04-30 | Campina Nederland Holding B.V. | Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same |
WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
PT1800675E (pt) | 2005-12-23 | 2011-08-30 | Nutricia Nv | COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA |
EP1992354B1 (en) | 2006-02-09 | 2014-04-09 | Calpis Co., Ltd. | Rheumatoid arthritis-preventive agent for oral intake |
EP2007792A2 (en) | 2006-03-22 | 2008-12-31 | DSMIP Assets B.V. | Cholesterol lowering protein hydrolysates |
WO2007116091A1 (en) | 2006-04-12 | 2007-10-18 | Dsm Ip Assets B.V. | Novel nutraceutical compositions |
CN101426513B (zh) | 2006-04-21 | 2013-05-01 | 株式会社明治 | 含有肽作为有效成分的组合物 |
NZ594814A (en) | 2006-04-28 | 2013-03-28 | Megmilk Snow Brand Co Ltd | Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent |
KR20080003637A (ko) | 2006-07-03 | 2008-01-08 | 한상기 | 다이어트효과가 우수한 기능성 유산균발효조성물 |
EP2164349B1 (en) | 2006-08-04 | 2014-09-10 | SHS International Ltd. | Protein free formula |
WO2008017415A1 (en) | 2006-08-09 | 2008-02-14 | Dsm Ip Assets B.V. | Casein complexes |
NL1032840C2 (nl) | 2006-11-09 | 2008-05-13 | Friesland Brands Bv | Probiotische hydrolysaatvoeding voor kinderen. |
NL1033521C2 (nl) | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Kindervoedingen met geoptimaliseerde aminozuursamenstelling. |
CN101802197A (zh) | 2007-05-14 | 2010-08-11 | 比奥根艾迪克Ma公司 | 单链FC(ScFc)区、包含其的结合多肽及与其相关的方法 |
WO2008147562A2 (en) | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
WO2008153429A2 (en) | 2007-06-11 | 2008-12-18 | Uniwersytet Jagiellonski | A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use |
EP2187916A2 (en) | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Use of gluten exorphin c as a therapeutic agent |
JP5620106B2 (ja) | 2007-10-24 | 2014-11-05 | 株式会社糖鎖工学研究所 | 増強されたエフェクター機能を有するポリペプチド |
US8859210B2 (en) | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
JP5735734B2 (ja) | 2009-04-16 | 2015-06-17 | 雪印メグミルク株式会社 | 脂質代謝改善剤 |
EP2253324A1 (en) | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
EP2295535A1 (en) | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
ES2524067T3 (es) | 2009-12-04 | 2014-12-03 | Mjn U.S. Holdings Llc | Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia |
ES2569241T5 (es) | 2010-01-19 | 2019-09-11 | Abbott Lab | Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica |
CA2790996A1 (en) | 2010-02-24 | 2011-09-01 | Morinaga Milk Industry Co. Ltd. | Therapeutic agent for eating disorders |
EP2514435A1 (en) | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
US9700071B2 (en) * | 2012-03-26 | 2017-07-11 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
-
2013
- 2013-03-15 US US13/833,094 patent/US8889633B2/en active Active
-
2014
- 2014-03-11 NZ NZ710020A patent/NZ710020A/en not_active IP Right Cessation
- 2014-03-11 EP EP14717284.5A patent/EP2983531B1/en active Active
- 2014-03-11 ES ES14717284T patent/ES2736313T3/es active Active
- 2014-03-11 MX MX2015011934A patent/MX365415B/es active IP Right Grant
- 2014-03-11 WO PCT/US2014/023608 patent/WO2014150558A1/en active Application Filing
- 2014-03-11 CA CA2905799A patent/CA2905799C/en not_active Expired - Fee Related
- 2014-03-11 SG SG11201505689PA patent/SG11201505689PA/en unknown
- 2014-03-11 RU RU2015140269A patent/RU2015140269A/ru not_active Application Discontinuation
- 2014-03-11 PE PE2015001979A patent/PE20151978A1/es not_active Application Discontinuation
- 2014-03-11 CN CN201480015753.8A patent/CN105072928B/zh active Active
- 2014-03-11 MY MYPI2015702455A patent/MY172218A/en unknown
- 2014-03-11 BR BR112015018335A patent/BR112015018335A2/pt not_active IP Right Cessation
- 2014-03-11 AU AU2014237014A patent/AU2014237014B2/en active Active
- 2014-03-14 AR ARP140101035A patent/AR095332A1/es unknown
- 2014-03-14 TW TW103109602A patent/TW201521603A/zh unknown
- 2014-10-14 US US14/513,584 patent/US9457058B2/en active Active
-
2015
- 2015-09-11 PH PH12015502071A patent/PH12015502071B1/en unknown
-
2016
- 2016-05-03 HK HK16104998.6A patent/HK1216976A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PH12015502071A1 (en) | 2016-01-25 |
US20140271553A1 (en) | 2014-09-18 |
EP2983531B1 (en) | 2019-04-24 |
NZ710020A (en) | 2020-04-24 |
RU2015140269A (ru) | 2017-04-21 |
CA2905799A1 (en) | 2014-09-25 |
US8889633B2 (en) | 2014-11-18 |
EP2983531A1 (en) | 2016-02-17 |
HK1216976A1 (zh) | 2016-12-16 |
US20150093463A1 (en) | 2015-04-02 |
AU2014237014B2 (en) | 2018-02-22 |
CN105072928A (zh) | 2015-11-18 |
AR095332A1 (es) | 2015-10-07 |
WO2014150558A1 (en) | 2014-09-25 |
PH12015502071B1 (en) | 2016-01-25 |
TW201521603A (zh) | 2015-06-16 |
CA2905799C (en) | 2021-03-30 |
CN105072928B (zh) | 2021-02-12 |
US9457058B2 (en) | 2016-10-04 |
MY172218A (en) | 2019-11-18 |
SG11201505689PA (en) | 2015-08-28 |
AU2014237014A1 (en) | 2015-08-13 |
PE20151978A1 (es) | 2016-01-23 |
BR112015018335A2 (pt) | 2017-08-22 |
ES2736313T3 (es) | 2019-12-27 |
MX365415B (es) | 2019-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502071B1 (en) | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof | |
PH12018501355A1 (en) | Rsv f protein mutants | |
WO2015018528A8 (en) | Il-15 and il-15raplha sushi domain based modulokines | |
MX2019004810A (es) | Ácidos ribonucleicos mensajeros para aumentar respuestas inmunes y métodos para usarlos. | |
MX2017006866A (es) | Pares de unión para producción de péptidos. | |
WO2015048333A3 (en) | Nutritive polypeptides and formulations thereof, and methods of production and use thereof | |
WO2015048339A3 (en) | Compositions and formulations for non-human nutrition and methods of production and use thereof | |
JP2015514395A5 (es) | ||
PH12015502102B1 (en) | Reducing proinflammatory response | |
AU2018253611A1 (en) | Engineered pesticidal proteins | |
MX2023005421A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
WO2015185758A3 (en) | Preparation comprising factor viii and von willebrand factor peptides | |
EA201591609A1 (ru) | Варианты альфа-амилазы | |
MX2021000155A (es) | Moleculas de proteina multifuncionales que comprenden decorina y su uso. | |
PH12015502072B1 (en) | Nutritional compositions containing a peptide component and uses thereof | |
MY171183A (en) | Polypeptide glycosylated with sialylated sugar chain | |
MX2018013556A (es) | Polipeptidos variantes con rendimiento mejorado y uso de los mismos. | |
MX2016005978A (es) | Planta mutante. | |
WO2019103512A3 (ko) | 목적 단백질의 발현 효율을 증진시키기 위한 신규한 펩타이드 및 이를 포함하는 융합 단백질 | |
AU2011350442B2 (en) | Modified tamavidin | |
UA117785C2 (uk) | Виділений ентомотоксичний поліпептид | |
TH171537A (th) | องค์ประกอบทางโภชนาการที่มีส่วนประกอบเปปไทด์พร้อมสมบัติต้านการอักเสบ และการใช้ของมัน | |
TH165979B (th) | การลดการตอบสนองแบบส่งเสริมการอักเสบ | |
RU2013118470A (ru) | Индивидуальное средство для отпугивания акул |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |